These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29064651)

  • 1. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months.
    Vecchioli-Scaldazza C; Morosetti C
    Int Braz J Urol; 2018; 44(1):102-108. PubMed ID: 29064651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C; Morosetti C; Berouz A; Giannubilo W; Ferrara V
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study.
    Zhang Y; Wang S; Zu S; Zhang C
    PLoS One; 2021; 16(6):e0253040. PubMed ID: 34161360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
    Del Río-Gonzalez S; Aragon IM; Castillo E; Milla-España F; Galacho A; Machuca J; Lara MF; Herrera-Imbroda B
    Urology; 2017 Oct; 108():52-58. PubMed ID: 28687483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, multicenter, controlled study, comparing efficacy and safety of a new complementary and alternative medicine (CAM) versus Solifenacin Succinate in women with overactive bladder syndrome.
    Vecchioli-Scaldazza C; Morosetti C; Maruccia S; Casellato S; Rociola W; Illiano E; Garofalo F
    Arch Ital Urol Androl; 2017 Dec; 89(4):296-300. PubMed ID: 29473382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study.
    Scaldazza CV; Morosetti C; Giampieretti R; Lorenzetti R; Baroni M
    Int Braz J Urol; 2017; 43(1):121-126. PubMed ID: 28124534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined solifenacin and aclatonium in preventing dry mouth in patients with overactive bladder.
    Park HK; Kim HG; Yang DY; Choi WS; Paick SH; Chung H; Yang SK
    Low Urin Tract Symptoms; 2019 Jan; 11(1):56-60. PubMed ID: 28967201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients.
    Te Dorsthorst MJ; Heesakkers JPFA; van Balken MR
    Neurourol Urodyn; 2020 Feb; 39(2):702-706. PubMed ID: 31845404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Tibial Nerve Stimulation Improves Female Sexual Function in Women With Overactive Bladder Syndrome.
    Musco S; Serati M; Lombardi G; Lumi E; Parisi AI; Del Popolo G; Finazzi Agrò E
    J Sex Med; 2016 Feb; 13(2):238-42. PubMed ID: 26803455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience.
    Andersen K; Kobberø H; Pedersen TB; Poulsen MH
    Scand J Urol; 2021 Apr; 55(2):169-176. PubMed ID: 33635171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-perceived effectiveness and impact on quality of life of solifenacin in combination with an α-blocker in men with overactive bladder in Sweden: a non-interventional study.
    Henningsohn L; Kilany S; Svensson M; Jacobsen JL
    Aging Male; 2017 Dec; 20(4):266-276. PubMed ID: 28787230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.